The global trauma market continues to play a central role in orthopedics, surpassing $9 billion in sales in 2024 and representing 15% of the $62 billion orthopedic market. Projections suggest steady growth ahead, with revenues expected to reach $9.4 billion in 2025 and $10.7 billion by 2028, driven by important shifts across subsegments.
Foot & Ankle: Under Pressure but Poised to Rebound
Often considered the “last gem” of orthopedics, the foot and ankle segment remains attractive at more than $5 billion in size and a high single-digit growth trajectory. Volumes slowed in 2024 and have remained under pressure in 2025, yet long-term fundamentals remain strong, and the market is expected to recover as key procedures regain momentum.